Demonstrates improved HPV vaccination completion with early initiation in younger populations, suggesting targeted programs may be beneficial.
Our study supports advocating for initiating the HPV vaccine at a younger age and completing the series by 14 years old. Multi-component and culturally tailored programs are an effective means to increasing HPV vaccine uptake and decreasing the burden of HPV-associated cancers.
No takes yet. Share an insight, caveat, or question.
Calderón-Mora et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: